Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 364

1.

Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.

Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, Downs-Kelly E, Fisher C, Goldblum JR, Guillou L, Reid R, Rosai J, Sciot R, Mandahl N, Panagopoulos I.

Lab Invest. 2005 Mar;85(3):408-15.

2.

Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.

Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchère-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marquès B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F, Coindre JM.

Am J Surg Pathol. 2007 Sep;31(9):1387-402.

PMID:
17721195
3.

The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.

Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjö O, Rydholm A, Isaksson M, Mandahl N, Mertens F.

Genes Chromosomes Cancer. 2004 Jul;40(3):218-28.

PMID:
15139001
4.

Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.

Matsuyama A, Hisaoka M, Shimajiri S, Hayashi T, Imamura T, Ishida T, Fukunaga M, Fukuhara T, Minato H, Nakajima T, Yonezawa S, Kuroda M, Yamasaki F, Toyoshima S, Hashimoto H.

Am J Surg Pathol. 2006 Sep;30(9):1077-84.

PMID:
16931951
5.

Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.

Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N, Mertens F.

Cancer Genet Cytogenet. 2010 Jun;199(2):143-6. doi: 10.1016/j.cancergencyto.2010.02.011.

PMID:
20471519
6.

Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.

Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, Tayebwa J, Nord KH, Kindblom LG, Mertens F.

Am J Surg Pathol. 2014 Jun;38(6):801-8. doi: 10.1097/PAS.0000000000000158.

PMID:
24441665
7.

DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.

Matsuyama A, Hisaoka M, Shimajiri S, Hashimoto H.

Diagn Mol Pathol. 2008 Dec;17(4):237-40. doi: 10.1097/PDM.0b013e318166d205.

PMID:
18382348
8.

MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.

Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, Fletcher CD, Hornick JL.

Am J Surg Pathol. 2012 Oct;36(10):1444-51. doi: 10.1097/PAS.0b013e3182562bf8.

PMID:
22982887
9.

Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera.

Panagopoulos I, Möller E, Dahlén A, Isaksson M, Mandahl N, Vlamis-Gardikas A, Mertens F.

Genes Chromosomes Cancer. 2007 Feb;46(2):181-91.

PMID:
17117415
10.

FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.

Patel RM, Downs-Kelly E, Dandekar MN, Fanburg-Smith JC, Billings SD, Tubbs RR, Goldblum JR.

Am J Dermatopathol. 2011 Apr;33(2):140-3. doi: 10.1097/IAE.0b013e318176de80.

PMID:
21399449
11.

Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma.

Storlazzi CT, Mertens F, Nascimento A, Isaksson M, Wejde J, Brosjo O, Mandahl N, Panagopoulos I.

Hum Mol Genet. 2003 Sep 15;12(18):2349-58. Epub 2003 Jul 22.

12.

FUS-CREB3L2/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1.

Möller E, Hornick JL, Magnusson L, Veerla S, Domanski HA, Mertens F.

Clin Cancer Res. 2011 May 1;17(9):2646-56. doi: 10.1158/1078-0432.CCR-11-0145.

13.

The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.

Rose B, Tamvakopoulos GS, Dulay K, Pollock R, Skinner J, Briggs T, Cannon S.

J Orthop Surg Res. 2011 Mar 15;6:15. doi: 10.1186/1749-799X-6-15.

14.

Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Hisaoka M, Tsuji S, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, Ushijima M.

Diagn Mol Pathol. 1998 Apr;7(2):96-101.

PMID:
9785008
15.

A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.

Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA, Antonescu CR.

Genes Chromosomes Cancer. 2015 Jan;54(1):28-38. doi: 10.1002/gcc.22215. Epub 2014 Sep 18.

16.

EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma.

Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK.

Am J Surg Pathol. 2013 May;37(5):734-8. doi: 10.1097/PAS.0b013e31827560f8.

PMID:
23588368
17.

FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.

Yang X, Nagasaki K, Egawa S, Maruyama K, Futami H, Tsukada T, Yokoyama R, Beppu Y, Fukuma H, Shimoda T, et al.

Jpn J Clin Oncol. 1995 Dec;25(6):234-9.

PMID:
8523819
18.

Hyalinizing spindle cell tumor with giant rosettes arising in the lung: report of a case with FUS-CREB3L2 fusion transcripts.

Kim L, Yoon YH, Choi SJ, Han JY, Park IS, Kim JM, Chu YC, Kim YJ.

Pathol Int. 2007 Mar;57(3):153-7.

PMID:
17295648
19.

Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.

Schwarzbach MH, Koesters R, Germann A, Mechtersheimer G, Geisbill J, Winkler S, Niedergethmann M, Ridder R, Buechler MW, von Knebel Doeberitz M, Willeke F.

Oncogene. 2004 Sep 2;23(40):6798-805.

PMID:
15286712
20.

Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.

Rekhi B, Folpe AL, Deshmukh M, Jambhekar NA.

Pathol Oncol Res. 2011 Mar;17(1):145-8. doi: 10.1007/s12253-010-9277-3. Epub 2010 May 25.

PMID:
20499220
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk